This is a reason to go long though. Presence in over 38 countries requires capital to increase treatment centers and train Doctors.
- Also, every time they have expanded in new markets, revenues rose. They rose by about 43% between 2021 - 2023.
- Insurers in the Uk and Spain are increasingly accepting OncoSil treatment so this momentum just needs to persist.
This is a reason to go long though. Presence in over 38...
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.99M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $1.536K | 256K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 3371929 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 20140788 | 23 |
View Market Depth
| Last trade - 10.06am 03/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |